Lv3
230 积分 2022-09-21 加入
Interleukin-23 Inhibitors for Inflammatory Bowel Disease: Pivotal Trials and Practical Considerations
1天前
待确认
Targeting IL-23 for IBD: Rationale and Progress to Date
1天前
已完结
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
2个月前
已完结
Recent progress in structural studies on canonical TRP ion channels
7个月前
已完结
In Vivo Pharmacodynamic Method to Assess Complement C5a Receptor Antagonist Efficacy
9个月前
已完结
Structure, function and cellular expression of complement anaphylatoxin receptors
11个月前
已完结
C5a-C5aR1 axis controls mitochondrial fission to promote podocyte injury in lupus nephritis
11个月前
已完结
C5a receptor antagonism coming of age for vascular pathology
1年前
已完结
皖公网安备34019202002308
